{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:09Z","timestamp":1793158149921,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04811-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:44:30Z","timestamp":1784634270000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral delivery of anti-mCD80 nanobody-engineered probiotic bacterial nanovesicles for macrophage-targeted Il17ra silencing in colitis"],"prefix":"10.1186","volume":"24","author":[{"given":"Manli","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"4811_CR1","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2021","unstructured":"Turner D, Ricciuto A, Lewis A, D\u2019Amico F, Dhaliwal J, Griffiths AM, Bettenworth D, Sandborn WJ, Sands BE, Reinisch W, et al. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD. Gastroenterology. 2021;160:1570\u201383.","journal-title":"Gastroenterology"},{"key":"4811_CR2","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1053\/j.gastro.2021.09.076","volume":"162","author":"C Le Berre","year":"2022","unstructured":"Le Berre C, Ricciuto A, Peyrin-Biroulet L, Turner D. Evolving short- and long-term goals of management of inflammatory bowel diseases: getting it right, making it last. Gastroenterology. 2022;162:1424\u201338.","journal-title":"Gastroenterology"},{"key":"4811_CR3","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1053\/j.gastro.2022.01.024","volume":"162","author":"N Plevris","year":"2022","unstructured":"Plevris N, Lees CW. Disease Monitoring in Inflammatory Bowel Disease: Evolving Principles and Possibilities. Gastroenterology. 2022;162:1456\u2013e14751451.","journal-title":"Gastroenterology"},{"key":"4811_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1053\/j.gastro.2023.10.033","volume":"166","author":"PS Dulai","year":"2024","unstructured":"Dulai PS, Singh S, Jairath V, Wong E, Narula N. Integrating evidence to guide use of biologics and small molecules for inflammatory bowel diseases. Gastroenterology. 2024;166:396-408.e392.","journal-title":"Gastroenterology"},{"key":"4811_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41575-024-01029-5","volume":"22","author":"L Katsidzira","year":"2025","unstructured":"Katsidzira L, Misselwitz B. Biologic agents for IBD come of age as host\u2013microbe interactions emerge. Nat Reviews Gastroenterol Hepatol. 2025;22:94\u20135.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"4811_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones GR, Bain CC. Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2023;20:538\u201353.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4811_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41575-025-01063-x","volume":"22","author":"V Solitano","year":"2025","unstructured":"Solitano V, Bernstein CN, Dotan I, Dignass A, Domilici R, Dubinsky MC, et al. Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response. Nat Rev Gastroenterol Hepatol. 2025;22:438\u201352.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4811_CR8","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.immuni.2022.08.005","volume":"55","author":"M Delfini","year":"2022","unstructured":"Delfini M, Stakenborg N, Viola MF, Boeckxstaens G. Macrophages in the gut: Masters in multitasking. Immunity. 2022;55:1530\u201348.","journal-title":"Immunity"},{"key":"4811_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41423-024-01218-x","volume":"21","author":"D Ohara","year":"2024","unstructured":"Ohara D, Takeuchi Y, Hirota K. Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells. Cell Mol Immunol. 2024;21:1183\u2013200.","journal-title":"Cell Mol Immunol"},{"key":"4811_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-71136-1","author":"T Muto","year":"2026","unstructured":"Muto T, Ito G, Katsuda H, Hiraguri Y, Fujii S, Yamamoto K, et al. IL-22 induces Paneth cell metaplasia in the colonic epithelium of ulcerative colitis, promoting wound healing via REG3A. Nat Commun. 2026;17(1):4568. https:\/\/doi.org\/10.1038\/s41467-026-71136-1","journal-title":"Nat Commun"},{"key":"4811_CR11","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.apsb.2020.02.002","volume":"10","author":"K Kuerban","year":"2020","unstructured":"Kuerban K, Gao X, Zhang H, Liu J, Dong M, Wu L, Ye R, Feng M, Ye L. Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer. Acta Pharm Sinica B. 2020;10:1534\u201348.","journal-title":"Acta Pharm Sinica B"},{"key":"4811_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41579-023-00875-5","volume":"21","author":"M Toyofuku","year":"2023","unstructured":"Toyofuku M, Schild S, Kaparakis-Liaskos M, Eberl L. Composition and functions of bacterial membrane vesicles. Nat Rev Microbiol. 2023;21:415\u201330.","journal-title":"Nat Rev Microbiol"},{"key":"4811_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59354-5","volume":"16","author":"HB Thapa","year":"2025","unstructured":"Thapa HB, Passegger CA, Fleischhacker D, Kohl P, Chen Y-C, Kalawong R, et al. Enrichment of human IgA-coated bacterial vesicles in ulcerative colitis as a driver of inflammation. Nat Commun. 2025;16:3995.","journal-title":"Nat Commun"},{"key":"4811_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202403199","volume":"36","author":"Y Xia","year":"2024","unstructured":"Xia Y, Zhang J, Liu G, Wolfram J. Immunogenicity of extracellular vesicles. Adv Mater. 2024;36:2403199.","journal-title":"Adv Mater"},{"key":"4811_CR15","doi-asserted-by":"publisher","first-page":"2501081","DOI":"10.1002\/adma.202501081","volume":"37","author":"Y You","year":"2025","unstructured":"You Y, Liu M, Yan N, Zhu D, Cheng X, Hu Y, Li Y, Qin Z, Zhu Z, Cheng K. Smart Materials and Devices for Enhanced Delivery of Extracellular Vesicles. Adv Mater. 2025;37:2501081.","journal-title":"Adv Mater"},{"key":"4811_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310174","volume":"36","author":"C Li","year":"2024","unstructured":"Li C, Wang ZX, Xiao H, Wu FG. Intestinal delivery of probiotics: materials, strategies, and applications. Adv Mater. 2024;36:e2310174.","journal-title":"Adv Mater"},{"key":"4811_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409138","volume":"36","author":"M Zu","year":"2024","unstructured":"Zu M, Liu G, Xu H, Zhu Z, Zhen J, Li B, et al. Extracellular vesicles from nanomedicine-trained intestinal microbiota substitute for fecal microbiota transplant in treating ulcerative colitis. Adv Mater. 2024;36:2409138.","journal-title":"Adv Mater"},{"key":"4811_CR18","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jconrel.2022.09.043","volume":"351","author":"M Song","year":"2022","unstructured":"Song M, Cui M, Fang Z, Liu K. Advanced research on extracellular vesicles based oral drug delivery systems. J Control Release. 2022;351:560\u201372.","journal-title":"J Control Release"},{"key":"4811_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.addr.2021.03.020","volume":"173","author":"M Richter","year":"2021","unstructured":"Richter M, Vader P, Fuhrmann G. Approaches to surface engineering of extracellular vesicles. Adv Drug Deliv Rev. 2021;173:416\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"4811_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s44222-025-00310-9","volume":"3","author":"L Pourtalebi Jahromi","year":"2025","unstructured":"Pourtalebi Jahromi L, Fuhrmann G. A chemical toolbox for surface engineering of extracellular vesicles. Nat Reviews Bioeng. 2025;3:617\u20139.","journal-title":"Nat Reviews Bioeng"},{"key":"4811_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33436-0","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Yu M, Ma L, Fu J, Guo J, Lei J, et al. In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis. Nat Commun. 2022;13:5700.","journal-title":"Nat Commun"},{"issue":"1","key":"4811_CR22","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou J, Li M, Chen Q, Li X, Chen L, Dong Z, et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 2022;13:3432.","journal-title":"Nat Commun"},{"key":"4811_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jconrel.2024.01.051","volume":"367","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Yin W, Yang Z, Sun J, Chang J, Huang L, et al. Nanotechnology-enabled M2 macrophage polarization and ferroptosis inhibition for targeted inflammatory bowel disease treatment. J Control Release. 2024;367:339\u201353.","journal-title":"J Control Release"},{"key":"4811_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122843","volume":"314","author":"T Li","year":"2025","unstructured":"Li T, Li Q, Liu S, Cao J, Mei J, Gong J, et al. Targeted V-type peptide-decorated nanoparticles prevent colitis by inhibiting endosomal TLR signaling and modulating intestinal macrophage polarization. Biomaterials. 2025;314:122843.","journal-title":"Biomaterials"},{"key":"4811_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500781","volume":"12","author":"Y Yang","year":"2025","unstructured":"Yang Y, Yang L, Yang Y, Deng H, Su S, Xia Y, et al. Bacteroides fragilis-derived outer membrane vesicles deliver miR-5119 and alleviate colitis by targeting PD-L1 to inhibit GSDMD-mediated neutrophil extracellular trap formation. Adv Sci (Weinh). 2025;12:e00781.","journal-title":"Adv Sci (Weinh)"},{"key":"4811_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-69382-4","volume":"17","author":"J Cao","year":"2026","unstructured":"Cao J, Luo R, Miao R, Li W, Zhu B, Yu L, et al. Engineered exosome nanovesicles for delivery of antibodies to treat inflammatory bowel disease. Nat Commun. 2026;17:2737.","journal-title":"Nat Commun"},{"key":"4811_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ado6798","volume":"10","author":"R Luo","year":"2024","unstructured":"Luo R, Liu J, Cheng Q, Shionoya M, Gao C, Wang R. Oral microsphere formulation of M2 macrophage-mimetic Janus nanomotor for targeted therapy of ulcerative colitis. Sci Adv. 2024;10:eado6798.","journal-title":"Sci Adv"},{"key":"4811_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202413261","volume":"35","author":"J Han","year":"2025","unstructured":"Han J, Ye J, Shi J, Fan Y, Yuan X, Li R, et al. A programmable oral nanomotor microcapsule for the treatment of inflammatory bowel disease. Adv Funct Mater. 2025;35:2413261.","journal-title":"Adv Funct Mater"},{"key":"4811_CR29","doi-asserted-by":"publisher","first-page":"e2503903","DOI":"10.1002\/advs.202503903","volume":"12","author":"R Wang","year":"2025","unstructured":"Wang R, Zhu J, Zhou J, Li J, Wang M, Wu Y, Zhao D, Chen X, Chen X, Wang Y, Zou J. Bioinspired Claw-Engaged Adhesive Microparticles Armed with \u03b3GC Alleviate Ulcerative Colitis via Targeted Suppression of Macrophage Ferroptosis. Adv Sci (Weinh). 2025;12:e2503903.","journal-title":"Adv Sci (Weinh)"},{"key":"4811_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123339","volume":"321","author":"Y Fu","year":"2025","unstructured":"Fu Y, Wang T, Ge X, Wen H, Fei Y, Li M, et al. Orally-deliverable liposome-microgel complexes dynamically remodel intestinal environment to enhance probiotic ulcerative colitis therapy via TLR4 inhibition and tryptophan metabolic crosstalk. Biomaterials. 2025;321:123339.","journal-title":"Biomaterials"},{"key":"4811_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.162727","volume":"512","author":"J Chen","year":"2025","unstructured":"Chen J, Wei C, Pan C, Wei Y, Li B, Liu T, et al. Genetically engineered Bacillus subtilis-derived extracellular vesicles alleviates ulcerative colitis by restoring intestinal barrier and regulating gut microbiota. Chem Eng J. 2025;512:162727.","journal-title":"Chem Eng J"},{"key":"4811_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bioactmat.2024.11.004","volume":"45","author":"GC Njoku","year":"2025","unstructured":"Njoku GC, Forkan CP, Soltysik FM, Nejsum PL, Pociot F, Yarani R. Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn\u2019s disease therapy. Bioactive Mater. 2025;45:41\u201357.","journal-title":"Bioactive Mater"},{"issue":"6478","key":"4811_CR33","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. https:\/\/doi.org\/10.1126\/science.aau6977","journal-title":"Science"},{"key":"4811_CR34","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-012418-012718","volume":"15","author":"M Locati","year":"2020","unstructured":"Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15:123\u201347.","journal-title":"Annu Rev Pathol"},{"key":"4811_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41572-020-0205-x","volume":"6","author":"T Kobayashi","year":"2020","unstructured":"Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, Bernstein CN, Danese S, Peyrin-Biroulet L, Hibi T. Ulcerative colitis. Nat Rev Dis Primers. 2020;6:74.","journal-title":"Nat Rev Dis Primers"},{"key":"4811_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, Kaser A, Peyrin-Biroulet L, Danese S. Crohn\u2019s disease. Nat Rev Dis Primers. 2020;6:22.","journal-title":"Nat Rev Dis Primers"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04811-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:02:19Z","timestamp":1792152139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4811"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04811-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures complied with institutional and national regulations and were approved by the Institutional Animal Care and Use Committee of The First Hospital of Jilin University (20240603-01).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors of this study agreed to publish.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"959"}}